972 filings
Page 35 of 49
424B5
ACER
Acer Therapeutics Inc.
7 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
ACER
Acer Therapeutics Inc.
7 Feb 11
Results of Operations and Financial Condition
12:00am
8-K
ACER
Acer Therapeutics Inc.
5 Jan 11
Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin® in Multiple Sclerosis
12:00am
8-K
ACER
Acer Therapeutics Inc.
9 Nov 10
Results of Operations and Financial Condition
12:00am
10-Q
2010 Q3
ACER
Acer Therapeutics Inc.
Quarterly report
9 Nov 10
12:00am
8-K
ACER
Acer Therapeutics Inc.
22 Oct 10
Departure of Directors or Certain Officers
12:00am
DEFA14A
ACER
Acer Therapeutics Inc.
14 Sep 10
Additional proxy soliciting materials
12:00am
DEF 14A
ACER
Acer Therapeutics Inc.
Definitive proxy
14 Sep 10
12:00am
RW
ACER
Acer Therapeutics Inc.
14 Sep 10
Registration withdrawal request
12:00am
10-Q
2010 Q2
ACER
Acer Therapeutics Inc.
Quarterly report
6 Aug 10
12:00am
8-K
ACER
Acer Therapeutics Inc.
6 Aug 10
Opexa Therapeutics Reports Second Quarter 2010 Financial Results
12:00am
8-K
ACER
Acer Therapeutics Inc.
7 Jun 10
Regulation FD Disclosure
12:00am
8-K
ACER
Acer Therapeutics Inc.
3 Jun 10
Termination of a Material Definitive Agreement
12:00am
8-K
ACER
Acer Therapeutics Inc.
17 May 10
Entry into a Material Definitive Agreement
12:00am
424B5
ACER
Acer Therapeutics Inc.
17 May 10
Prospectus supplement for primary offering
12:00am
8-K
ACER
Acer Therapeutics Inc.
13 May 10
Opexa Therapeutics Reports First Quarter 2010 Financial Results
12:00am
10-Q
2010 Q1
ACER
Acer Therapeutics Inc.
Quarterly report
13 May 10
12:00am
8-K
ACER
Acer Therapeutics Inc.
27 Apr 10
Departure of Directors or Certain Officers
12:00am
8-K
ACER
Acer Therapeutics Inc.
5 Mar 10
Opexa Therapeutics Reports Year End 2009 Financial Results
12:00am
10-K
2009 FY
ACER
Acer Therapeutics Inc.
Annual report
5 Mar 10
12:00am